Left ventricular function was assessed in 10 patients with alcoholic cirrhosis and ascites without clinical evidence of heart disease. In the resting state pulmonary wedge pressure (PWP) was normal (average 9.7 mm Hg), cardiac output (CO) was elevated (average 9.7 L/min) and systemic vascular resistance (SVR) was low (average 825 dynes-sec-cm-5). During infusion of angiotensin in a dose sufficient to raise diastolic arterial pressure 20 mm Hg, SVR increased to 1140 dynes-sec-cm-5 (P<0.01) and PWP rose to 19.2 mm Hg (P<0.001) with no change in CO. Resting hemodynamics were essentially unchanged in seven patients restudied 45-60 min after intravenous administration of 0.5 mg ouabain. Repeat infusion of angiotensin after ouabain again resulted in a rise in PWP to an average of 17.0 mm Hg (P < 0.001) with no significant change in CO. In seven additional cirrhotic patients with ascites, systolic time intervals were unchanged by 0.5 mg ouabain whereas in four normal volunteers the same dose resulted in significant shortening of total electromechanical systole, pre-ejection period and left ventricular ejection time. These data indicate that depression of the left ventricular response to an increase in afterload is a uniform finding in alcoholic patients with cirrhosis and ascites. The absence of clinical symptoms of heart disease, therefore, could be attributed to the low systemic vascular resistance characteristic of cirrhosis. Since acute administration of ouabain neither improved left ventricular function nor altered systolic time intervals, digitalis may have a limited place in the therapy of this form of cardiac impairment.
SUMMARY
Left ventricular function was assessed in 10 patients with alcoholic cirrhosis and ascites without clinical evidence of heart disease. In the resting state pulmonary wedge pressure (PWP) was normal (average 9.7 mm Hg), cardiac output (CO) was elevated (average 9.7 L/min) and systemic vascular resistance (SVR) was low (average 825 dynes-sec-cm-5). During infusion of angiotensin in a dose sufficient to raise diastolic arterial pressure 20 mm Hg, SVR increased to 1140 dynes-sec-cm-5 (P<0.01) and PWP rose to 19.2 mm Hg (P<0.001) with no change in CO. Resting hemodynamics were essentially unchanged in seven patients restudied 45-60 min after intravenous administration of 0.5 mg ouabain. Repeat infusion of angiotensin after ouabain again resulted in a rise in PWP to an average of 17.0 mm Hg (P < 0.001) with no significant change in CO. In seven additional cirrhotic patients with ascites, systolic time intervals were unchanged by 0.5 mg ouabain whereas in four normal volunteers the same dose resulted in significant shortening of total electromechanical systole, pre-ejection period and left ventricular ejection time. These data indicate that depression of the left ventricular response to an increase in afterload is a uniform finding in alcoholic patients with cirrhosis and ascites. The absence of clinical symptoms of heart disease, therefore, could be attributed to the low systemic vascular resistance characteristic of cirrhosis. Since acute administration of ouabain neither improved left ventricular function nor altered systolic time intervals, digitalis may have a limited place in the therapy of this form of cardiac impairment.
Additional Indexing Words:
Systolic time intervals Systemic vascular resist R ECENT hemodynamic," 2 metabolic3 and structural4 studies in man and experimental animals have emphasized the deleterious effect on the heart of chronic alcohol ingestion. Despite the evidence that links excessive alcohol ingestion with some cases of "primary" cardiomyopathy,5-7 cardiac impairment has not generally been thought to be an important factor in the course of the alcoholic patient with chronic liver disease. Therefore, although abnormal renal retention of sodium is a prominent feature of both heart failure and cirrhosis, a cardiac role in the etiology of cirrhotic ascites and edema usually is not considered.
The purpose of the present study was to evaluate left ventricular function in patients with alcoholic liver disease and ascites in the absence of clinical signs or symptoms of cardiac dysfunction. Evidence of impaired cardiac response to an increased afterload was noted in every subject, and the effects of acute digitalization were therefore evaluated.
Methods
Studies were performed on 10 patients with a longstanding history of heavy alcohol intake and hospitalized because of accumulation of moderate or massive ascites. Portal (alcoholic) cirrhosis had been diagnosed by liver biopsy (seven patients) and/or clinical findings (ten patients). The patients were studied after an average period of hospitalization (and abstinence from alcohol) of 12 days (range: 3-18 days). All were eating salt-restricted hospital diets with vitamin supplementation prior to study. Pertinent clinical data are summarized in table 1. All patients were males; six were white and four were black. Their ages ranged from 39 to 63 (average, 45 years). None of the patients had hypertension, valvular heart disease, angina pectoris or previous history of an acute myocardial infarction. They were free of symptoms referable to the cardiovascular system and physical examination of the heart and lungs was unremarkable except for the presence of a soft fourth heart sound in three patients. Electrocardiograms and chest X-rays were normal in all patients.
Right heart catheterization was performed using a Swvan-Ganz flow directed balloon-tipped catheter (Edwards Laboratory, Santa Ana, California) inserted percutaneously via an antecubital vein. Arterial blood pressure was measured through a cannula in the brachial artery. Pressures were recorded using Statham P23Db or Bell and Howell strain gauge transducers. Cardiac output (CO) in liters/mim was determined by the indicator dilution technique with indocyanine green injected into the pulmonary artery and sampled from the brachial artery using a Waters or Gilford cuvette densitometer. Stroke work in gm-m was calculated from the formula (MAP-PWP) (SV) (.0136), where MAP is mean arterial pressure in mm Hg, PWP is mean pulmonary artery wedge pressure in mm Hg and SV is stroke volume in ml. Systemic vascular resistance (SVR) in dynes-sec-cm-5 was calculated from the formula (MAP -RAP) (80/CO), where RAP is mean right atrial pressure in mm Hg.
Angiotensin solution was prepared by dissolving Hypertensin (Ciba) powder in normal saline to a final concentration of 1 ,ug/ml. The solution was given at a constant rate by a Harvard infusion pump. Following control hemodynamic measurements angiotensin was infused at an initial rate of 1.48 gtg/min, wvhich was increased every 10 minutes until the diastolic arterial pressure increased by 20 mm Hg. Maximum dose required was 9.96 ,ug/min. Hemodynamic measurements were repeated when arterial pressure had stabilized at the highest level. In seven of these ten patients, 0.5 mg ouabain was injected intravenously after the arterial pressure had returned to control levels. Hemodynamic studies were repeated 45-60 minutes later before and during infusion of angiotensin.
In seven additional patients with alcoholic cirrhosis and ascites and in four normal volunteers systolic time intervals were measured before aind 45 min after the intravenous injection of 0.5 mg ouabaini. The phonocardiogram, carotid pulse wave and electrocardiogram (lead II) were recorded simultaneously on a Hewlett Packard recorder at a paper speed of 100 mm/sec. Measurements were taken over five sequential cardiac cycles and the results were averaged. Electromechanical systole (QS2) was taken as the interval between the initial deflection of the Q wave and the second heart sound; left ventricular ejection time (LVET) was defined as the interval between the initial upstroke of the carotid pulse and incisura. Pre-ejection period (PEP) was determined by subtracting LVET from QS ,. 8 The results were corrected for heart rate according to regression equations previously determined in this laboratory.') Data are reported as the corrected indices, QS&1, LVETI, and PEP,.
Results
Hemodynamic data on the 10 patients studied are shown in table 2. The resting intracardiac pressures were within normal limits. CO ranged from 4.9 to 18.0 L/min (mean 9.7 L/min) and SV ranged from 57 to 211 ml (mean 116 ml). Systemic vascular resistance averaged 830 10 dynes-sec-cm-5. During angiotensin infusion the PWP rose from 9.7+1.8 mm Hgto 19.2+1.5 mm Hg (P<0.001) and mean PA pressure increased from 15.8 2.7 to 25.3 + 4.1 mm Hg (P < 0.001). CO remained essentially unchanged (9.6 + 1.5 L/min during angiotension infusion compared to 9.7 1.4 L/min control). Since heart rate declined during angiotensini infusion (85 + 4 to 75 + 4 beats/min), CO was maintained by an increase in stroke volume. The increase in arterial pressure therefore was associated with a rise in SVR from an average of 825 + 10 to 1140 + 15 dynes-sec-cm-5.
As shown in figure 1, during infusion of angiotensin small increases in stroke work were realized at the expense of a prominent rise in left Relationship between stroke work and left ventricular filling pressure before and during angiotensin infusion in 10 patients with alcoholic cirrhosis. Dots represent control observations and arrow heads represent values during angiotensin infusion. Heavy line and arrow depicts the mean for the group.
ventricular filling pressure; in two patients, a small decrease in stroke work accompanied angiotensin infusion. Stroke work increased by 17% during angiotensin infusion whereas PWP rose by an average of 98%.
Resting hemodynamic measurements were not significantly changed 45 to 60 minutes following administration of 0.5 mg ouabain. Infusion of angiotensin after ouabain demonstrated persistent impairment of left ventricular function ( fig. 2 ). Pulmonary arterial pressure and PWP rose consistently from 13.6 1.3 to 24.0 1.8 mm 'Hg and from 9.7 0.8 to 17.0 + 1.2 mm Hg, respectively, while cardiac output fell insignificantly from 10.6 + 1.8 to 9.5 + 1.4 L/min. The average percentage increase in systemic vascular resistance during angiotensin infusion was essentially the same during the control and post-ouabain periods (45% and 40%, respectively). Relationship between stroke work and left ventricular filling pressure during angiotensin infusion in seven patients before (control) and after (ouabain) acute digitalization. C = values obtained immediately before angiotensin infusion; A = values obtained at the peak of the angiotensin effect. Vertical and horizontal lines represent + one standard error from the mean. 
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In the four normal subjects injection of ouabain resulted in shortening of the systolic time intervals: QS2, decreased by 11%, PEP, by 21%, and LVETI by 6% (table 3 ). In contrast, systolic time intervals remained essentially unchanged in the cirrhotic patients.
Discussion
None of the ascitic patients with alcoholic liver disease included in this study were thought to have clinically significant cardiac impairment. Indeed, the high resting cardiac output noted in these subjects often is viewed as evidence that cardiac performance is normal.10. 11 Nonetheless, modest increases in afterload induced by an infusion of angiotensin precipitated a striking increase in pulmonary wedge pressure in each of the patients without a concomitant rise in stroke work. This response differs from that seen in normal subjects, in whom an angiotensin-induced increase of about 20 mm Hg in arterial pressure usually is accompanied by a small change in LVEDP and a large increase in stroke work.'12 13 Although direct left ventricular catheterization in the present study might have provided more precise data regarding left ventricular performance, it was not felt to be justified. Furthermore, PWP should provide a reliable guide to changes in left ventricular end-diastolic pressure14 even during infusion of angiotensin, which has little Circulation, Volume XLIX, April 1974 75S if any direct effect on the pulmonary vascular bed. 15 The rise in PWP observed during angiotensin infusion in the patients with very high resting CO might suggest the possibility that their hearts were operating on the flat portion of a normal left ventricular function curve. However, four of the 10 patients had CO less than 8 L/min and these subjects exhibited a similar abnormal response to angiotensin infusion.
These observations of impared left ventricular function are in accordance with those of Gould and his associates,5 who demonstrated an abnormal hemodynamic response to exercise in patients with chronic liver disease and normal cardiac findings except for a presystolic gallop. Spodick, Pigott and Chirife16 also have recently demonstrated abnormal systolic time intervals indicative of impaired cardiac function in alcoholic subjects without signs of heart disease. Thus, left ventricular dysfunction appears to be an almost universal finding in alcoholic patients and may coexist with a high cardiac output secondary to a reduced peripheral vascular resistance. Indeed, the low systemic vascular resistance characteristic of the cirrhotic circulation may mask the signs of cardiac impairment which may then be made apparent when the vascular resistance and afterload are increased.
Although resting right atrial, pulmonary arterial and pulmonary capillary pressures were normal in these hospitalized ascitic patients, a cardiac contribution to their abnormal sodium retention cannot be disregarded. Since modest increases in afterload in the present studies and modest exercise in the studies of Gould and his associates produced abnormal elevations in cardiac filling pressures, it is likely that abnormal hemodynamics were present in these patients during usual activity prior to hospitalization. The cause of sodium retention in heart failure is not known, but abnormal tubular reabsorption of sodium is the primary renal mechanism.17 Intrarenal redistribution of blood flow and glomerular filtration away from the cortex has been demonstrated both in congestive heart failure and cirrhosis.18 Kew et al. 19 have demonstrated an abnormal intrarenal distribution of blood flow in patients with cirrhosis even in the compensated stage. It is possible, therefore, that sodium retention is partly related to renal hemodynamic alterations precipitated by abnormal cardiac function, which was invariably demonstrable in the ascitic cirrhotic patients studied.
In an attempt to test whether correction of the cardiac dysfunction would improve renal sodium Circulation, Volume XLIX, April 1974 handling, 0.5 mg ouabain was administered intravenously. However, no improvement in the left ventricular response to angiotensin infusion could be demonstrated within one hour after digitalis administration. A similar lack of response to digitalis was seen when the pre-ejection period or the electromechanical systolic interval were chosen as an index of contractility. In contrast normal subjects in the present study exhibited reduction of systolic time intervals after the same dose of ouabain, and Weissler and Schoenfeld20 have demonstrated a consistent effect on systolic time intervals in patients with congestive heart failure of other etiologies. These data suggest that ouabain administered acutely in these doses may be ineffective in increasing myocardial contractility in alcoholic cirrhotic patients. Although digitalis is employed routinely in the management of clinical heart disease in alcoholic patients, few studies to document its effectiveness have been reported.21-23 Acute administration of 0.5-0.75 mg ouabain did not improve the hemodynamic abnormalities of 5 patients with primary myocardiopathy studied by Massumi and his co-workers. 19 Furthermore, Spodick, Pigott and Chirife16 found marked abnormalities in systolic time intervals in alcoholic patients with cardiomyopathy despite treatment with digitalis. In contrast, cardiac index increased and LVEDP decreased following acute digitalization of two patients with primary myocardiopathy studied by Murphy et al.22 Gould et al.23 noted reversal of the abnormal hemodynamic response to exercise after digitalization of some alcoholic patients.
Whether the absence of response to ouabain in the present studies could be related to an inadequate dose, possibly because of distribution of the drug in a larger extracellular volume in these ascitic patients, or to failure of the contractile machinery to respond to an appropriate dose level cannot be determined. Further studies perhaps using a larger dose or longer observation period are needed before the potential role of digitalis in the cardiac functional abnormality in cirrhotic subjects can be established.
